Pubblicazioni

NRF2 activation in BONâ1 neuroendocrine cancerÂ cells reduces the cytotoxic effects of a novel Ruthenium(II)âcurcumin compound: A pilot study

2024 - ONCOLOGY REPORTS

Garufi, Alessia; Pettinari, Riccardo; Monteonofrio, Laura; Puliani, Giulia; Virdia, Ilaria; Appetecchia, Marialuisa; Marchetti, Fabio; Cirone, Mara; Soddu, Silvia; D'Orazi, Gabriella

Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death

2018 - ONCOLOGY REPORTS

Passacantilli, I.; Panzeri, V.; Terracciano, F.; Fave, G. D.; Sette, C.; Capurso, G.

Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells

2016 - ONCOLOGY REPORTS

Coccia, Andrea; Mosca, Luciana; Puca, Rosa; Mangino, Giorgio; Rossi, Alessandro; Lendaro, Eugenio

Pubblicazioni

NRF2 activation in BONâ1 neuroendocrine cancerÂ cells reduces the cytotoxic effects of a novel Ruthenium(II)âcurcumin compound: A pilot study

Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death

Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells

NRF2 activation in BONâ1 neuroendocrine cancerÂ cells reduces the cytotoxic effects of a novel Ruthenium(II)âcurcumin compound: A pilot study